Filing Details
Summit Therapeutics Inc. (NASDAQ:SMMT) filed a Form 8-K with the Securities and Exchange Commission on August 05, 2026, disclosing a material event.
8k filedNASDAQ:SMMT
Summit Therapeutics Inc. (SMMT) Reports Material Event to SEC
Filing Details Summit Therapeutics Inc. (NASDAQ:SMMT) filed a Form 8-K with the Securities and Exchange Commission on August 05, 2026, disclosing a material event. Market Context…
Market Context
Summit Therapeutics Inc.'s stock currently trades at $13.53 with a market capitalization of $13.4B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Summit Therapeutics Inc.'s stock.
All SEC filings for Summit Therapeutics Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View SMMT Stock Page
Frequently Asked Questions
Where can I read SMMT's SEC filings?
Browse all filings on our SMMT SEC filings page.
What types of SEC filings does Summit Therapeutics Inc. file?
Public companies like Summit Therapeutics Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.